AngioSculpt RX PTCA
Scoring balloon catheter
AngioSculpt RX PTCA scoring balloon catheter significantly alters the landscape for treating CAD, offering the advanced performance that only an innovative clinical solution can provide. The AngioSculpt RX PTCA scoring balloon catheter is the only specialty scoring device indicated for ISR and complex type-C lesions.
Advanced molded, tapered tip
New tip designed for improved delivery.
Precision: Edges locked in
Achieve proper placement as AngioSculpt's rectangular scoring edges lock the device in place. AngioSculpt has minimal device slippage or “watermelon seeding,” even in ISR.¹
Power: ~15 – 25x scoring force
AngioSculpt RX PTCA has an enhanced mechanical advantage. The leading edges are designed to drive outward expansion with up to 15–25 times the force of conventional balloons.² The helical nitinol scoring element creates a large luminal expansion for stent implantation.³
Safety: ~1x force post-scoring
Get predictable results with AngioSculpt RX PTCA. Post-scoring, outward forces are designed to be equivalent to that of a conventional balloon. AngioSculpt RX PTCA has a low dissection rate of 13.6% (majority were non-flow limiting).¹